Latest clinical trial News | Page 15

Drug shows promise for motor neuron disease
Why do some people who take Paxlovid for COVID get ‘rebound’ symptoms?
Hormonal breast cancer treatment reduces long-term risk of recurrence
Austrade’s advisers help NSW medtech enter 18 new markets
Genetic Signatures completes recruitment in pivotal clinical trial
Amplia Therapeutics’ trial to be presented at major US conference
Pictures speak louder than words: pioneering psychosis therapy trial launches
UQ research recognised in national biomedical incubator
Inhalable Covid Vaccine Shows Promise in Rodent Model
Mobile kidney disease testing
‘Pap smears’ can be replaced by do-it-yourself cervical cancer tests
McGowan Government strengthens medical research commitment with WA Office of Medical Research and Innovation
New drug delivery system improves treatment of atherosclerosis
New AI platform for people with genetic disorders
Managing insomnia with an app
New scholars to honour Evelyn Lavu
AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases
Dimerix enters agreement for new trial of DMX-200 in diabetic kidney disease
Future fund supports clinical trial on steroid use for pre-term babies
Of lab frustration and magic hands
Ludwig Johns Hopkins study establishes utility of circulating tumor DNA for post-surgical management of stage II colon cancer
COVID kidney injury twice as common as diagnosed
First patient recruited in Dimerix late-stage trial
Research to improve lives of children with juvenile arthritis
Adherium provides update on senior management
Cynata Therapeutics adds new site for MEND clinical trial
MRFF funding to advance research into blood cancer and neurological conditions in children
New clinical trial to test cancer drug in motor neuron disease
Scientists smash lethal bacteria that acts like hammer
WHO validates 11th vaccine for Covid
AnteoTech’s updated Covid RAT receives regulatory approval in Europe
Schmitz receives $3.2 million to bring supportive cancer care to rural areas
Pandemic Science Hub to fight lung disease
Volunteers needed to trial scar-less wound healing cream
PT027, novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine
NeuroScientific Biopharmaceuticals submits for approval of early-phase trial
Volunteers receive first dose in clinical trial of Melbourne-made Covid vaccines
Texas Medical Center and Biodesign Australia announce partnership
Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial
First subjects randomised and dosed in Paradigm’s late-stage trial
Adherium releases next generation respiratory platform integration services
Promising combination therapy for triple-negative breast cancer
NSW Government seeks operator for RNA manufacturing
WHO recommends highly successful Covid therapy and calls for wide geographical distribution and transparency from originator
Imugene says first cohort two patient dose in phase 1 clinical trial
New National PTSD Centre brings new hope to trauma survivors
$15 million to support Mitochondrial disease research
Australian research to support children with Mitochondrial disease